Physicians Financial Services Inc. Has $295,000 Position in American Express Company (AXP)
Physicians Financial Services Inc. continued to hold its stake in shares of American Express Company (NYSE:AXP) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,500 shares of the payment services company’s stock at the close of the 2nd quarter. Physicians Financial Services Inc.’s holdings in American Express were worth $295,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of AXP. BlackRock Inc. boosted its stake in shares of American Express by 2,686.0% in the 1st quarter. BlackRock Inc. now owns 44,177,867 shares of the payment services company’s stock valued at $3,494,913,000 after purchasing an additional 42,592,136 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of American Express by 21.7% in the 1st quarter. Wellington Management Group LLP now owns 17,198,787 shares of the payment services company’s stock valued at $1,360,596,000 after purchasing an additional 3,071,573 shares in the last quarter. Tesco Pension Investment Ltd acquired a new stake in shares of American Express in the 1st quarter valued at $137,325,000. OppenheimerFunds Inc. boosted its stake in shares of American Express by 40.1% in the 1st quarter. OppenheimerFunds Inc. now owns 3,627,184 shares of the payment services company’s stock valued at $286,946,000 after purchasing an additional 1,038,328 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of American Express by 9.4% in the 1st quarter. Bank of New York Mellon Corp now owns 10,274,363 shares of the payment services company’s stock valued at $812,804,000 after purchasing an additional 879,569 shares in the last quarter. Institutional investors own 82.77% of the company’s stock.
Shares of American Express Company (AXP) opened at 90.46 on Friday. The stock has a 50 day moving average price of $85.80 and a 200-day moving average price of $81.62. The company has a market capitalization of $79.96 billion, a PE ratio of 18.55 and a beta of 1.18. American Express Company has a 52 week low of $59.50 and a 52 week high of $90.77.
American Express (NYSE:AXP) last posted its quarterly earnings data on Wednesday, July 19th. The payment services company reported $1.47 EPS for the quarter, topping the Zacks’ consensus estimate of $1.44 by $0.03. The company had revenue of $8.31 billion for the quarter, compared to analyst estimates of $8.20 billion. American Express had a return on equity of 21.90% and a net margin of 14.11%. The firm’s quarterly revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.10 earnings per share. Equities research analysts expect that American Express Company will post $5.74 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, October 6th will be paid a $0.35 dividend. This is a positive change from American Express’s previous quarterly dividend of $0.32. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend is Thursday, October 5th. American Express’s payout ratio is currently 26.18%.
American Express declared that its board has approved a share buyback program on Wednesday, June 28th that authorizes the company to repurchase $4.40 billion in outstanding shares. This repurchase authorization authorizes the payment services company to purchase up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.
In related news, insider Susan Sobbott sold 6,000 shares of American Express stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $84.39, for a total value of $506,340.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Vice Chairman Stephen J. Squeri sold 94,792 shares of American Express stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $85.41, for a total value of $8,096,184.72. Following the completion of the transaction, the insider now directly owns 261,665 shares in the company, valued at $22,348,807.65. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 949,387 shares of company stock worth $80,451,099. 0.67% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Physicians Financial Services Inc. Has $295,000 Position in American Express Company (AXP)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/01/physicians-financial-services-inc-has-295000-position-in-american-express-company-axp.html.
Several equities research analysts have recently commented on the stock. BidaskClub upgraded shares of American Express from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Zacks Investment Research upgraded shares of American Express from a “hold” rating to a “buy” rating and set a $96.00 target price on the stock in a research note on Tuesday, August 29th. Instinet restated an “underperform” rating and issued a $80.00 target price on shares of American Express in a research note on Thursday, June 29th. Barclays PLC restated a “buy” rating and issued a $83.00 target price on shares of American Express in a research note on Thursday, July 20th. Finally, Stephens upgraded shares of American Express from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $70.00 to $82.00 in a research note on Tuesday, June 20th. Three investment analysts have rated the stock with a sell rating, sixteen have given a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $86.29.
American Express Profile
American Express Company, together with its subsidiaries, is a global services company. The Company’s principal products and services are charge and credit card products, and travel-related services, which are offered to consumers and businesses around the world. Its segments include the U.S. Consumer Services (USCS), International Consumer and Network Services (ICNS), Global Commercial Services (GCS) and Global Merchant Services (GMS).
Want to see what other hedge funds are holding AXP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Express Company (NYSE:AXP).
Receive News & Stock Ratings for American Express Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Express Company and related stocks with our FREE daily email newsletter.